People who took Zepbound had greater reductions in waist circumference and body weight, a study found.Fact checked by Nick ...

Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...

Eli Lilly is a global healthcare giant, generating strong growth from a diverse portfolio of blockbuster medications. Viking ...

Regeneron isn’t the only Big Pharma to spot potential in Hansoh’s obesity pipeline. Merck & Co. ended last year paying $112 ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

A new study to be presented at the SLEEP 2025 annual meeting found that sleep medicine professionals favor continuous ...

The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...

Zepbound is a weekly injectable prescription weight loss medication with the active ingredient tirzepatide. It’s a GLP-1 agonist drug that slows stomach emptying, meaning you feel fuller for longer.

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

The direct-to-consumer telehealth company said the workforce reduction is unrelated to its weight-loss drug sector.

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...